Thu. 4 Apr 2024, 7:02am ET
Benzinga
Earnings, News
AngioDynamics (NASDAQ:ANGO) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.13) by 23.08 percent. This is a 433.33 percent decrease over losses of $(0.03) per share from the same period last year. The company reported quarterly sales of $75.18 million which missed the analyst consensus estimate of $75.73 million by 0.72 percent. This is a 6.85 percent decrease over sales of $80.71 million the same period last year.